NTrans Technologies

About:

NTrans Technologies offers a proprietary platform technology for the intracellular delivery of bioactive molecules.

Website: https://www.ntranstechnologies.com/

Top Investors: EASME - EU Executive Agency for SMEs

Description:

NTrans Technologies offers a proprietary platform technology for the intracellular delivery of bioactive molecules. The company is further developing this technology for both research and clinical purposes as a method for the delivery of biologicals that is safe, non-toxic, highly efficient, and easy to use. NTrans Technologies' goal is to be a leader in technologies for the transduction of proteins and other bioactive molecules into primary cells.